Skip to main content

Table 2 Scores on Secondary Outcome Measures Before and After Lamotrigine Treatment

From: A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control

Measure

Pre

M (SD)

Post

M (SD)

p

Cohen’s d

BEST

39.89 (5.46)

29.11 (3.82)

0.008

2.29

ZAN-BPD

28.89 (4.11)

21.11 (5.90)

0.008

1.53

EDE-Q Scores

 Restraint

2.8 (1.5)

1.3 (0.9)

0.058

1.21

 Eating Concern

2.9 (1.7)

2.2 (1.4)

0.093

0.45

 Shape Concern

4.7 (1.2)

3.3 (1.6)

0.093

0.99

 Weight Concern

4 (1.8)

3.4 (1.5)

0.406

0.36

 Global

3.7 (1.4)

2.7 (1)

0.051

0.82

BDI-II

30.7 (15.4)

24.2 (12.4)

0.314

0.46

STAI State

60.2 (11.4)

60.2 (12.1)

0.799

0

STAI Trait

54 (8.9)

56.1 (10.6)

0.373

−0.21

  1. Note: Presented p values represent the results of exploratory related-samples Wilcoxon signed rank tests; EDE-Q = Eating Disorder Examination Questionnaire; STAI = State-Trait Anxiety Inventory; BDI = Beck Depression Inventory